- Home
- WDH vs ANAB Comparison
WDH vs ANAB Comparison
Compare WDH & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- ANAB
- Stock Information
- Founded
- WDH 2016
- ANAB 2005
- Country
- WDH China
- ANAB United States
- Employees
- WDH N/A
- ANAB N/A
- Industry
- WDH Specialty Insurers
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- WDH Finance
- ANAB Health Care
- Exchange
- WDH Nasdaq
- ANAB Nasdaq
- Market Cap
- WDH 651.0M
- ANAB 621.1M
- IPO Year
- WDH 2021
- ANAB 2017
- Fundamental
- Price
- WDH $1.84
- ANAB $20.22
- Analyst Decision
- WDH
- ANAB Buy
- Analyst Count
- WDH 0
- ANAB 10
- Target Price
- WDH N/A
- ANAB $48.00
- AVG Volume (30 Days)
- WDH 278.4K
- ANAB 459.5K
- Earning Date
- WDH 09-04-2025
- ANAB 08-06-2025
- Dividend Yield
- WDH 2.21%
- ANAB N/A
- EPS Growth
- WDH 118.23
- ANAB N/A
- EPS
- WDH 0.15
- ANAB N/A
- Revenue
- WDH $388,729,415.00
- ANAB $123,164,000.00
- Revenue This Year
- WDH N/A
- ANAB N/A
- Revenue Next Year
- WDH $9.29
- ANAB $24.39
- P/E Ratio
- WDH $11.81
- ANAB N/A
- Revenue Growth
- WDH 3.35
- ANAB 304.17
- 52 Week Low
- WDH $0.97
- ANAB $12.21
- 52 Week High
- WDH $2.17
- ANAB $40.70
- Technical
- Relative Strength Index (RSI)
- WDH 58.63
- ANAB 34.66
- Support Level
- WDH $1.76
- ANAB $19.48
- Resistance Level
- WDH $1.86
- ANAB $20.35
- Average True Range (ATR)
- WDH 0.07
- ANAB 1.27
- MACD
- WDH -0.01
- ANAB -0.13
- Stochastic Oscillator
- WDH 65.83
- ANAB 18.49
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).